Anti-Alzheimer Agents from Marine Sources
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 32207
Special Issue Editors
Interests: carbohydrate small molecule synthesis; organic and biomolecular chemistry developments towards new therapeutic approaches for diabetes; Alzheimer’s disease and other amyloid diseases and carbohydrate-based antibiotics
Special Issues, Collections and Topics in MDPI journals
Interests: lipidomics; seafood; nutrition; benefits of omega-3 fatty acids in health; biotechnology applied to micro- and macroalgae utilization in human food and feeds; marine biomolecules; functional ingredients such as squalene, phytosterols, EPA and DHA
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This issue aims at the valorization of marine resources for the prevention/control of Alzheimer’s disease (AD).
Algae and microalgae are, indeed, a source of important substances known to prevent/delay the onset of neurodegenerative diseases, and papers on topics related to their study are welcome, particularly those highlighting their bioactive components that act against neurodegeneration. However, other marine organisms also have the potential to treat AD, namely sponges. Moreover, several prospective observational studies clearly point to the protective effect of fish consumption against the risk of AD. This Special Issue aims to give an overview of the important contribution of all the marine resources for the generation of new compounds or the usefulness of their known components with the aim of controlling AD. This issue also intends to contribute to the better understanding of the link between dietary components and the state of cognitive functions, exploring different steps that separate a food ingestion from the bioactivity of its components in neurons. Furthermore, papers will shed light on the dose response relation between bioactive compounds and cognitive function. Synthetic approaches to their bioactive compounds are also welcome, as well as studies on their mechanisms of action.
Prof. Dr. Amélia Pilar Rauter
Prof. Dr. Narcisa M. Bandarra
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Algae
- Microalgae
- Sponges
- Marine organisms
- Analysis
- Bioactive natural products isolation and characterization
- Synthesis
- Mechanism of action
- DHA
- Toxins